ISHAC Overview :: Nationwide Children's Hospital

ISHAC Overview

Congenital heart disease (CHD) is a relatively common childhood disorder. While new transcatheter and surgical treatments have improved patient outcomes, many challenges remain. The Hybrid approach strives to further enhance clinical results by combining surgical and interventional management strategies, with the goal of diminishing the risks associated with the individual procedures. Additionally, it reduces the cumulative risks associated with multiple interventions.

ISHAC remains a unique forum where a 2-day Symposium is coupled with a special 1-day Skills Workshop. Attendees will learn the latest clinical and research developments in Hybrid therapies from our prestigious international faculty. Over the years, we have had faculty and participants from over 34 states, 50 countries, and 6 continents; we expect this year to be no exception. ISHAC truly has something for everyone - surgeons, cardiologists, anesthesiologists, nurses and nurse practitioners, perfusionists, allied health professionals, and research scientists. There will be didactic lectures, moderated discussions, live case demonstrations, special noon presentations with box lunches, tours of the Hybrid Suites at Nationwide Children's Hospital, and direct access to our faculty for questions and answers. This year, procedures will be performed from Hybrid Suites at Rush Medical Center in Chicago, Miami Children's Hospital, and Nationwide Children's Hospital... with special Hybrid procedures broadcast from out University Laboratory Animal Resources Experimental Surgical Suites (ULAR).

We are especially proud of the 1-day Skills Workshop at ULAR to be held on Tuesday, August 31st, which requires a separate registration and has limited attendance. Registrants will work directly with our faculty and have hands-on experience with many forms of Hybrid therapies in our specially designed animal models. The Workshop is truly unique and allows the attendees to return to their own institutions to initiate, expand, and improve Hybrid therapies.

Purpose

 

ISHAC should enable participants to:

  1. Compare clinical outcomes between Hybrid and traditional approaches to CHD in deciding optimal treatment options.

  2. Implement innovative evidence-based approaches to CHD management.

  3. Utilize research and multi-center outcomes data to determine care options for infants, children and adults with CHD.

  4. Acquire clinical skills with new Hybrid treatments and devices. (Skills Workshop only)

ISHAC Testimonial from Gdansk, Poland

Department of Pediatric Cardiac Surgery Province Hospital of Gdansk, Poland

Thanks again for marvelous stay at Nationwide Childrens Hospital, Columbus, Ohio. We were really impressed observing your cathlab and OR activities, especially Hybrid procedures and transcatheter valve implantation. Since the visit we started our first hybrid procedures in our institutio, we performed two infant periventricular muscular-VSD closure with pretty good results. Our first patient was 9-months old girl with a history of coarctation repair and PA-banding due to multiple VSDs, that were finally closed periventricularly with 8 mm Amplatzer Muscular VSD Occluder via sternotomy. The second is an intact baby girl who received VSD Occluder implantation because of multi-VSDs, 6 kg 5 months, who is really the youngest and smallest child who underwent Hybrid procedure in Poland. We take the program really seriously while building our new center, and we expect to develop Hybrid team in the institution. The next 3 babies are listed as candidates to Hybrid VSD occlusion. We reached the license to Hybrid program from the Polish Ministry of Health.

We are sure that this all would have not be possible without your contribution, so we highly appreciate your help.

Ireneusz Haponiuk and Maciej Chojnicki, Poland

Department of Pediatric Cardiac Surgery Province Hospital of Gdansk, Poland

Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000